Medical Procedures
Explore procedure pages with patient-friendly context about preparation, expectations, and recovery.
Procedures starting with F (3,781)
Other
Fetal 22q11.2 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Other
Fetal 5p deletion prior risk [Likelihood] based on general population risk
Other
Fetal 5p deletion prior risk [Likelihood] based on general population risk Narrative
Other
Fetal 5p deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Other
Fetal 5p deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Other
Fetal 5p deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Other
Fetal Angelman syndrome prior risk [Likelihood] based on general population risk
Other
Fetal Angelman syndrome prior risk [Likelihood] based on general population risk Narrative
Other
Fetal Angelman syndrome risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Other
Fetal Angelman syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Other
Fetal Angelman syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Other
Fetal Biophysical profile panel US
Other
Fetal Chorion [Type]
Other
Fetal Chromosome 13 trisomy [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Other
Fetal Chromosome 13 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Other
Fetal Chromosome 13 trisomy [Presence] based on Plasma cell-free DNA by Sequencing
Other
Fetal Chromosome 13+18+21 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Other
Fetal Chromosome 13+18+21+X+Y aneuploidy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Other
Fetal Chromosome 18 trisomy [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Other
Fetal Chromosome 18 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Other
Fetal Chromosome 18 trisomy [Presence] based on Plasma cell-free DNA by Sequencing
Other
Fetal Chromosome 21 trisomy [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Other
Fetal Chromosome 21 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Other
Fetal Chromosome 21 trisomy [Presence] based on Plasma cell-free DNA by Sequencing
Other
Fetal Chromosome X and Y aneuploidy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Other
Fetal Chromosome X and Y aneuploidy [interpretation] based on dosage of chromosome-specific cell-free DNA in Maternal plasma
Other
Fetal Chromosome X and Y aneuploidy risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Other
Fetal Chromosome X and Y aneuploidy risk [interpretation] in Plasma cell-free DNA Qualitative by Sequencing
Other
Fetal Chromosome region 11q23 deletion [Presence] based on Plasma cell-free DNA by Sequencing
Other
Fetal Chromosome region 15q11 deletion [Presence] based on Plasma cell-free DNA by Sequencing
Other
Fetal Chromosome region 4p16 deletion [Presence] based on Plasma cell-free DNA by Sequencing
Other
Fetal Chromosome region 8q24 deletion [Presence] based on Plasma cell-free DNA by Sequencing
Other
Fetal Danforth operation
Fetal Danforth operation — clinical procedure (SNOMED CT 304968002).
Other
Fetal Danforth operation
Fetal Danforth operation — clinical procedure (SNOMED CT 70186003).
Other
Fetal Document Fetal Heart Tracing
Other
Fetal Document Vital signs measurements
Other
Fetal Heart rate
Other
Fetal Heart rate by Auscultation
Other
Fetal Maternal age
Other
Fetal Microdeletions risk [interpretation] in Plasma cell-free DNA Qualitative by Sequencing
Other
Fetal Monosomy X prior risk [Likelihood] Based on maternal age
Other
Fetal Monosomy X prior risk [Likelihood] Based on maternal age Narrative
Other
Fetal Monosomy X risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Other
Fetal Monosomy X risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Other
Fetal Monosomy X risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Other
Fetal Monosomy X risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Other
Fetal Movement - Reported
Other
Fetal Narrative Movement
Other
Fetal Neural tube defect risk [Likelihood] Based on maternal age
Other
Fetal Prader-Willi syndrome prior risk [Likelihood] based on general population risk
Other
Fetal Prader-Willi syndrome prior risk [Likelihood] based on general population risk Narrative
Other
Fetal Prader-Willi syndrome risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Other
Fetal Prader-Willi syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Other
Fetal Prader-Willi syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Other
Fetal Pregnancy risk factors for prenatal genetic testing
Other
Fetal Reason for death
Other
Fetal RhD antigen in Plasma cell-free DNA by MS.MALDI-TOF
Other
Fetal Secondary cause of death
Other
Fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Other
Fetal Trisomy 13 prior risk [Likelihood] Based on maternal age
Other
Fetal Trisomy 13 prior risk [Likelihood] Based on maternal age Narrative
Other
Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Other
Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Other
Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Other
Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Other
Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Other
Fetal Trisomy 18 prior risk [Likelihood] Based on maternal age
Other
Fetal Trisomy 18 prior risk [Likelihood] Based on maternal age Narrative
Other
Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Other
Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free DNA by Sequencing Qualitative
Other
Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Other
Fetal Trisomy 18 risk [Likelihood] Based on maternal age
Other
Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Other
Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Other
Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Other
Fetal Trisomy 21 prior risk [Likelihood] Based on maternal age
Other
Fetal Trisomy 21 prior risk [Likelihood] Based on maternal age Narrative
Other
Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Other
Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Sequencing Qualitative
Other
Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Other
Fetal Trisomy 21 risk [Likelihood] Based on maternal age
Other
Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Other
Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Other
Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Other
Fetal Y chromosome [Interpretation] based on Plasma cell-free DNA by Sequencing
Other
Fetal Y chromosome [Presence] based on Plasma cell-free DNA by Sequencing
Diagnostic
Fetal acoustic stimulation test
Fetal acoustic stimulation test — clinical procedure (SNOMED CT 252951006).
Other
Fetal anatomy study
Fetal anatomy study — clinical procedure (SNOMED CT 271442007).
Other
Fetal biophysical profile
Fetal biophysical profile — clinical procedure (SNOMED CT 21623001).
Other
Fetal blood [Volume] by Kleihauer-Betke method
Diagnostic
Fetal blood cell concentration measurement
Fetal blood cell concentration measurement — clinical procedure (SNOMED CT 250227002).
Other
Fetal blood sampling
Fetal blood sampling — clinical procedure (SNOMED CT 243773009).
Other
Fetal cell screen
Fetal cell screen — clinical procedure (SNOMED CT 104068001).
Other
Fetal chromosome 13+18+21+X+Y aneuploidy in Tissue by Molecular genetics method Nominal
Other
Fetal chromosome 13+18+21+Y aneuploidy [Presence] based on dosage of chromosome-specific cell-free DNA from Maternal plasma
Other
Fetal clavicotomy
Fetal clavicotomy — clinical procedure (SNOMED CT 62726004).
Other
Fetal craniotomy
Fetal craniotomy — clinical procedure (SNOMED CT 386561000).
Other
Fetal craniotomy
Fetal craniotomy — clinical procedure (SNOMED CT 11317001).
Other
Fetal death certificate
Other
Fetal decapitation
Fetal decapitation — clinical procedure (SNOMED CT 20891002).